Maplight Therapeutics files Form 144 for common stock

Maplight Therapeutics, Inc. submitted a Form 144 notice related to proposed sales of Common stock, filed with a broker address listed as Jefferies, 520 Madison Ave, New York.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submitted a Form 144 notice related to proposed sales of Common stock, filed with a broker address listed as Jefferies, 520 Madison Ave, New York. The filing date shown is 04/15/2026. The excerpt lists prior Restricted Stock Unit grants of 14,844, 7,664, and 24,222 shares with grant dates of 07/30/2023, 11/09/2023, and 05/02/2024, respectively.

Insights

Securities Attorney

Form 144 lists proposed resale of common stock tied to prior equity grants.

The filing is a procedural notice that a holder intends to sell restricted or control securities under resale rules. The excerpt shows broker information and three prior Restricted Stock Unit grants with explicit grant dates and share counts.

Timing, exact number of shares being offered for sale, and cash‑flow treatment are not specified in the excerpt; subsequent filings or a complete Form 144 would show the specific sale quantities and methods.

Key Figures

Form filing date: 04/15/2026 RSU grant (07/30/2023): 14,844 shares RSU grant (11/09/2023): 7,664 shares +1 more

4 metrics

Form filing date 04/15/2026 Form 144 header

RSU grant (07/30/2023) 14,844 shares Restricted Stock Unit Grant dated 07/30/2023

RSU grant (11/09/2023) 7,664 shares Restricted Stock Unit Grant dated 11/09/2023

RSU grant (05/02/2024) 24,222 shares Restricted Stock Unit Grant dated 05/02/2024

Key Terms

Restricted Stock Unit, Form 144, Jefferies

3 terms

Restricted Stock Unit financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Form 144 regulatory

"form_type: "144" in metadata and header lines"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Jefferies other

"Jefferies 520 Madison Ave New York NY 10022"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Maplight Therapeutics (MPLT) Form 144 mean?

It signals a notice of an intended resale of restricted or control securities under Rule 144. The excerpt lists broker details and grant history but does not state exact sale quantities or proceeds.

Which securities are listed in the MPLT excerpt?

The excerpt lists Common stock tied to Restricted Stock Unit grants. Grant counts shown are 14,844; 7,664; and 24,222 shares on the listed grant dates.

When was the Form 144 filing date shown for MPLT?

The filing date shown in the excerpt is 04/15/2026. The excerpt does not include closing or settlement dates for any sale activity.

Does this excerpt state how many shares will be sold for MPLT?

No. The excerpt lists prior RSU grant counts and dates but does not specify the number of shares proposed for sale or the sale method in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001658918
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE Redwood City CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Kroeger Christopher A.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies 520 Madison Ave New York NY 10022	20822	562610.44	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			14844	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			7664	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics Inc.			24222	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection w/RSU vesting
Date of Notice	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Christopher Kroeger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)